?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
June 24, 2021
signalgroup
Organon Joins Biosimilars Forum
News
June 21, 2021
signalgroup
Lowering Prices with Biosimilars: ASP+8: Stakeholder Meeting Round-Up
News
June 18, 2021
signalgroup
It’s time we fulfill the ACA’s promise to broaden access to lower-cost drugs
News
June 17, 2021
signalgroup
The Biosimilars Forum Applauds SCOTUS Decision to Uphold ACA and US Pathway for Biosimilar Approval
News
June 14, 2021
signalgroup
New Report Shows Biosimilars Significantly Lowered Prices of All Biologics
News
May 18, 2021
signalgroup
House Oversight Committee Spotlights Anticompetitive Practices Blocking Access to Lower Cost Biosimilars
News
April 30, 2021
signalgroup
Senators Cornyn and Bennet Introduce Bipartisan Legislation to Incentivize Biosimilars, Lower Cost for Seniors
News
April 28, 2021
signalgroup
Biosimilars Forum Calls for Bipartisan Policies That Lower Drug Prices on Expensive Biologics Ahead of President Biden’s Joint Session of Congress Address
News
April 27, 2021
signalgroup
Congressmen Tonko and Gibbs Introduce Bipartisan Legislation to Increase Transparency and Use of Biosimilars in Medicare Plans
News
April 26, 2021
signalgroup
President Biden Signs the Advancing Education on Biosimilars Act Into Law
Prev page
05
06
07
08
09
Next page